News
Liver transplant in CRC: Who might benefit?
- Author:
- M. Alexander Otto, PA, MMS
“It seems likely that there is a small group of patients with unresectable colorectal liver metastases who should be considered for transplant,...
News
Scalp cooling for chemo hair loss strikes out with patients
- Author:
- M. Alexander Otto, PA, MMS
“The efficacy and tolerability of [scalp cooling] applied in a clinical routine setting ... appeared to be limited.”
News
Cancer diagnoses, care access rise after Medicaid expansion
- Author:
- M. Alexander Otto, PA, MMS
In Ohio, researchers found a substantial increase in diagnoses for all three cancers among Medicaid patients after expansion.
News
FDA OKs dostarlimab plus chemo for endometrial cancer
- Author:
- M. Alexander Otto, PA, MMS
The trial results “and today’s approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-...
News
MRI-guided SBRT cuts radiation toxicity in prostate cancer
- Author:
- M. Alexander Otto, PA, MMS
“These findings suggest that the technical advantages in precision of radiotherapy delivery afforded by MRI-guided SBRT translate to measurable...
News
Routine thromboprophylaxis for advanced ovarian cancer?
- Author:
- M. Alexander Otto, PA, MMS
“Two-thirds [of VTEs] may have been preventable” because they occurred between epithelial ovarian cancer diagnosis and interval cytoreductive...
News
Palliative radiation therapy improves QoL in high-grade glioma
- Author:
- M. Alexander Otto, PA, MMS
“Short-course palliative hypofractionated radiotherapy in patients with poor-prognosis [high-grade glioma] does not impair QoL in the short term...
News
FDA approves quizartinib for newly diagnosed AML
- Author:
- M. Alexander Otto, PA, MMS
Cardiac risks mean the targeted tyrosine kinase inhibitor is available only through a Risk Evaluation and Mitigation Strategies program.
News
Radiation approach improves swallowing in head, neck cancer
- Author:
- M. Alexander Otto, PA, MMS
“DO-IMRT should be considered a new standard of care.”
News
Lower-dose FOLFIRINOX effective, safer for pancreatic cancer
- Author:
- M. Alexander Otto, PA, MMS
“The best dose modification protocol” remains to be determined and standardized for metastatic pancreatic cancer.
News
Was the fruquintinib trial for metastatic CRC a win?
- Author:
- M. Alexander Otto, PA, MMS
“One could debate if 2.6 months of more time is worth the medication getting regulatory approval, or debate pricing when it’s approved, or delve...
News
No benefit to adding limited radiation in advanced cancer
- Author:
- M. Alexander Otto, PA, MMS
Median overall survival was not significantly better with radiotherapy, compared with the control group, nor was the objective response rate.
News
Diabetes may short circuit pembrolizumab benefits in NSCLC
- Author:
- M. Alexander Otto, PA, MMS
"There is an urgent need to validate our findings and explore whether outcomes in these patients can be improved by better glycemic control."
News
FDA approves first gene therapy for hemophilia A
- Author:
- M. Alexander Otto, PA, MMS
The expensive, one-time, single-dose IV infusion for severe hemophilia A may offer patients years of freedom from infusions.
News
MRI identifies rectal cancer patients who can skip CRT
- Author:
- M. Alexander Otto, PA, MMS
Study suggests that neoadjuvant chemoradiation therapy can be restricted to patients at high risk of locoregional recurrence.